Felipe, PatricioMorales Davila, EliudPatricio Martinez, AleidyArana del Carmen, NayeliMartínez, IsabelAguilera, JoséPerez Aguilar, Jose ManuelLimón, Ilhuicamina Daniel2023-02-022023-02-022022-09-02https://hdl.handle.net/20.500.12371/17308"Cannabidiol (CBD) presents antiparkinsonian properties and neuromodulatory effects, possibly due to the pleiotropic activity caused at multiple molecular targets. Recently, the GPR55 receptor has emerged as a molecular target of CBD. Interestingly, GPR55 mRNA is expressed in the external globus pallidus (GPe) and striatum, hence, it has been suggested that its activity is linked to motor dysfunction in Parkinson’s disease (PD). The present study aimed to evaluate the effect of the intrapallidal injection of both CBD and a selective GPR55 antagonist (CID16020046) on motor asymmetry, fine motor skills, and GAD-67 expression in hemiparkinsonian rats. The hemiparkinsonian animal model applied involved the induction of a lesion in male Wistar rats via the infusion of the neurotoxin 6-hydroxydopamine (6-OHDA) into the medial forebrain bundle via stereotaxic surgery. After a period of twenty days, a second surgical procedure was performed to implant a guide cannula into the GPe".engCannabidiolCID16020046GPR55 receptorBehavioral testMotor asymmetryFine motor skillsParkinson's diseaseArtículoopenAccess